Latest Influenza treatment Stories

SILVER SPRING, Md., Oct. 23 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration announced today that, in response to a request from the U.S. Centers for Disease Control and Prevention, it has issued an emergency use authorization (EUA) for the investigational antiviral drug peramivir intravenous (IV) in certain adult and pediatric patients with confirmed or suspected 2009 H1N1 influenza infection who are admitted to a hospital. (Logo:...

SILVER SPRING, Md., Oct. 15 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today warned consumers to use extreme care when purchasing any products over the Internet that claim to diagnose, prevent, treat or cure the H1N1 influenza virus. The warning comes after the FDA recently purchased and analyzed several products represented online as Tamiflu (oseltamivir), which may pose risks to patients. (Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO ) One of the...

PRINCETON, N.J., Oct. 14 /PRNewswire/ -- Weekly Digest (http://www.bullmarket.com/digest), a free investment research publication, announced the publication of a special report on investment opportunities in the connection with the H1N1 "Swine Flu" Outbreak, including updated outlooks for Gilead Sciences (Nasdaq: GILD), Sinovac Biotech (Amex: SVA), Dynavax Technologies (Nasdaq: DVAX), Hemispherx BioPharma (Amex: HEB), BioCryst Pharmaceuticals (Nasdaq: BCRX) and several others. After posting...

NAPLES, Fla., Oct. 13 /PRNewswire/ -- The 21st century is seeing renewed interest in traditional and alternative medicine, with a particular focus on herbs and botanicals that have long been thought to have therapeutic qualities. One of those botanicals is elderberry, which for centuries has been used as a home remedy for upper respiratory health to ward off infection. Now, researchers at HerbalScience Group have employed advanced scientific methods and innovative technology to uncover the...

According to a report issued on Friday by the World Health Organization (WHO), early treatment with swine flu antiviral medications serves as an effective treatment against the now infamous H1N1 flu.While conceding that there have been relatively few incidences of drug-resistant pandemic flu viruses, WHO officials continue to speak of the need to diligently monitor all new outbreaks for signs of drug resistance.On their website, the WHO stated there has been no new evidence that...

SAN FRANCISCO, Sept. 13 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that two new observational studies concluded that influenza patients treated with Tamiflu(R) (oseltamivir phosphate) had significantly higher survival rates than untreated patients. The studies, examining nearly 1,000 people, analyzed outcomes for two different groups -adults and children diagnosed with the highly pathogenic A (H5N1) avian influenza and adults hospitalized with seasonal influenza....

Treating people with H1N1 flu with anti-virals oseltamivir and zanamivir should only be considered for those at high risk of complications, U.S. officials say. The Centers for Disease Control and Prevention's Mortality and Morbidity Weekly Report released Thursday says oseltamivir resistance was found in pandemic H1N1 virus from two patients who developed influenza while taking oseltamivir. The patients attended a summer camp in North Carolina where oseltamivir was given to most campers and...

British researchers reported on Friday that the flu drugs Tamiflu and Relenza might not be worthwhile to treat seasonal influenza in healthy adults. "Recommending the use of antiviral drugs for the treatment of people presenting with symptoms is unlikely to be the most appropriate course of action," wrote Jane Burch of the University of York and colleagues.Their findings support an advisory from the World Health Organization (WHO) that says healthy patients who get H1N1 swine flu...

A meta-analysis found anti-virals such as Tamiflu and Relenza may not help children with novel H1N1 flu, or swine flu, a researcher in Britain said. Matthew Shun-Shin of John Radcliffe Hospital and Oxford University in England and colleagues conducted systematic review of data from published and unpublished randomized controlled trials using anti-virals in children younger than age 12. Eligible studies included four randomized trials of treatment of influenza -- two with Tamiflu two with...

Countries around the world are stockpiling two common anti-influenza drugs -- Relenza and Tamiflu -- for possible use in the current H1N1 flu pandemic, as well as for future influenza pandemics.In response to this recent phenomenon, researchers from the Stanford University School of Medicine pooled and analyzed data from seven previously published studies, which showed these two drugs appear equally effective at preventing flu symptoms when given before infection, although neither drug has...